XOMA Royalty to acquire Generation Bio
Source: SeekingAlpha
2025-12-15 17:28:52 ET
More on XOMA, Generation Bio
- XOMA Royalty PFD Update: Going Back To My Original Sell Ratings
- XOMA extends tender offer for LAVA Therapeutics to Oct 17
- Seeking Alpha’s Quant Rating on XOMA
- Historical earnings data for XOMA
- Financial information for XOMA
Read the full article on Seeking Alpha
For further details see:
XOMA Royalty to acquire Generation Bio
XOMA Royalty Corporation
NASDAQ: XOMA
XOMA Trading
-2.81% G/L:
$26.115 Last:
55,535 Volume:
$27.17 Open:
XOMA Latest News
March 12, 2026 06:30:00 am
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
February 09, 2026 09:53:00 am
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
December 30, 2025 07:30:00 am
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
XOMA Stock Data
$281,901,340
10,055,080
0.24%
24
N/A
Biotechnology & Life Sciences
Healthcare
US
Emeryville
